Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata treatment should consider life quality and mental health, not just clinical results.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

The document emphasizes early detection and treatment of men's skin conditions and recommends protective measures and appropriate treatments for different age groups.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.